Cargando…

Editorial: EBV Infection and Human Primary Immune Deficiencies

Detalles Bibliográficos
Autores principales:	Cohen, Jeffrey I., Meyts, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025461/ https://www.ncbi.nlm.nih.gov/pubmed/32117278 http://dx.doi.org/10.3389/fimmu.2020.00130

Ejemplares similares

Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice
por: Schuhmachers, Patrick, et al.
Publicado: (2021)

Editorial: The Complexity of Primary Antibody Deficiencies
por: Quinti, Isabella, et al.
Publicado: (2021)

Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations
por: Hashem, Hasan, et al.
Publicado: (2022)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023)

EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency
por: Schipp, Cyrill, et al.
Publicado: (2018)

Revisiting the Tissue Microenvironment of Infectious Mononucleosis: Identification of EBV Infection in T Cells and Deep Characterization of Immune Profiles
por: Barros, Mário Henrique M., et al.
Publicado: (2019)

PD-L1 is upregulated in CD163+ tonsillar macrophages from children undergoing EBV primary infection
por: Moyano, Agustina, et al.
Publicado: (2022)

Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma
por: Farina, Antonella, et al.
Publicado: (2021)

CD70 Deficiency due to a Novel Mutation in a Patient with Severe Chronic EBV Infection Presenting As a Periodic Fever
por: Caorsi, Roberta, et al.
Publicado: (2018)

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey
por: Chan, Alice Y., et al.
Publicado: (2020)

Editorial: Exploring Immune Variability in Susceptibility to Tuberculosis Infection in Humans
por: Seshadri, Chetan, et al.
Publicado: (2022)

Primary Immune Deficiencies – Principles of Care
por: Chapel, Helen, et al.
Publicado: (2014)

Gene Therapies for Primary Immune Deficiencies
por: Kohn, Lisa A., et al.
Publicado: (2021)

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
por: Hong, Junping, et al.
Publicado: (2022)

Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases
por: Ballow, Mark, et al.
Publicado: (2022)

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
por: Cui, Xinle, et al.
Publicado: (2021)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
por: Couturaud, Barbara, et al.
Publicado: (2023)

Editorial: Immunity to Parasitic Infections in Pregnancy
por: Doritchamou, Justin Y. A., et al.
Publicado: (2021)

Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
por: Tatfi, Moussab, et al.
Publicado: (2019)

GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies
por: Zhang, Xi, et al.
Publicado: (2023)

Update on Infections in Primary Antibody Deficiencies
por: Demirdag, Yesim Yilmaz, et al.
Publicado: (2021)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome
por: Padeira, Gonçalo Luzes, et al.
Publicado: (2021)

A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors
por: Yonkof, Jennifer R., et al.
Publicado: (2020)

GATA2 Deficiency and Epstein–Barr Virus Disease
por: Cohen, Jeffrey I.
Publicado: (2017)

Editorial: Structural and Computational Glycobiology – Immunity and Infection
por: Agostino, Mark, et al.
Publicado: (2015)

EBV-associated diseases: Current therapeutics and emerging technologies
por: Chakravorty, Srishti, et al.
Publicado: (2022)

Innate immune modulation in EBV infection
por: Ning, Shunbin
Publicado: (2011)

Editorial: The Autophagy Pathway: Bacterial Pathogen Immunity and Evasion
por: Jagannath, Chinnaswamy, et al.
Publicado: (2021)

Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy
por: Gonzalez, Juan Marcos, et al.
Publicado: (2022)

Editorial: Regulation of Immunity to Parasitic Infections Endemic to Africa
por: Osier, Faith, et al.
Publicado: (2020)

Editorial: Immunity to Cytomegalovirus Infections: Challenges and Therapeutic Opportunities
por: Alonso-Arias, Rebeca, et al.
Publicado: (2022)

Editorial: Neonatal host immune responses to pulmonary infections
por: Empey, Kerry M., et al.
Publicado: (2023)

Editorial: Regulation of Immunity by Non-Immune Cells
por: Dainichi, Teruki, et al.
Publicado: (2021)

Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies
por: Grammatikos, Alexandros, et al.
Publicado: (2021)

A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept
por: Satgé, Daniel
Publicado: (2018)

Editorial: Host immune response and protective immune responses during filarial infections
por: Ritter, Manuel, et al.
Publicado: (2022)

Editorial: Modulation of Human Immune Parameters by Anticancer Therapies
por: Sack, Ulrich, et al.
Publicado: (2020)

Editorial: Mathematical Modeling of the Immune System in Homeostasis, Infection and Disease
por: Bocharov, Gennady, et al.
Publicado: (2020)

Editorial: The Effects of Physical Activity and Exercise on Immune Responses to Infection
por: Dutra, Patricia M. L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hti8kvc9k7dgsv7mcpbe9d6ule